Summary
This 8-K filing from Edwards Lifesciences Corporation, dated October 19, 2012, announces the company's financial results for the third quarter of 2012. The primary purpose of this report is to furnish a press release containing these operational and financial outcomes, which is incorporated by reference. Investors should note that this information, as per Item 2.02, is furnished and not deemed "filed" under the Securities Exchange Act of 1934.
Key Highlights
- 1Edwards Lifesciences filed an 8-K on October 19, 2012.
- 2The filing pertains to the company's financial results for the third quarter of 2012.
- 3A press release detailing these results is attached as Exhibit 99.1.
- 4The press release is furnished under Item 2.02 of the 8-K.
- 5Information furnished under Item 2.02 is not considered "filed" for regulatory purposes.
- 6The report indicates the Chief Financial Officer, Thomas M. Abate, signed off on the filing.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce and provide investors with Edwards Lifesciences' financial and operational results for the third quarter of 2012, as detailed in an accompanying press release.
The specific financial results for the third quarter of 2012 are contained within the press release furnished as Exhibit 99.1 to this 8-K filing.
This 8-K filing primarily furnishes a press release. While the press release will contain a summary of the Q3 2012 financial results, it typically does not include the full, detailed financial statements as would be found in a Form 10-Q or 10-K.
When information is 'furnished' under Item 2.02, it means the company is providing it to the SEC but is not subject to the same liability and disclosure requirements as if it were 'filed.' This is a common practice for earnings releases.